How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
Signs of Life
As you have read in the past few issues and in the issues to come, we have covered the upcoming technologies in the fields of biomedical and scientific imaging. This issue is no different. Check out our cover story on 3D medical imaging by Iain Goddard, Hartmut Schirmacher and Malte Westerhoff (page 10), Mike May’s third installment on biomedical imaging (page 24) and Barry Mazor’s Roundtable on biomedical imaging (page 28).
Recent events offer proof of signs of life in the medical imaging community. Back in April, ChromaVision Medical Systems, the San Juan Capistrano, CA-based company, was granted US Patent # 6,718,053, "Method and Apparatus for Automated Image Analysis of Biological Specimens,nbsp" which extends broad coverage to the company’s FDA 510K-cleared Automated Cellular Imaging Systems (ACIS), its mechanisms of operation and its general purposes.
Even government entities are working together. Back in May, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the National Cancer Institute (NCI), along with the National Aeronautics and Space Administration (NASA) and the National Science Foundation (NSF), conducted a workshop on image-guided interventions (IGI). The purpose of the workshop was to promote interdisciplinary team science and to provide recommendations to ensure that the National Institutes of Health (NIH), NASA and NSF programs address important needs and issues associated with IGI. The agenda was aimed at covering a broad spectrum of technological advances related to image-guided technologies. You can learn more about his by logging on to www.nibib.nih.gov/events/IGI2004.
The RSNA has reported that, thanks to advanced CT and MR imaging technology — along with new clinical research — radiologists are finding their roles increased in diagnosing and treating stroke. According to Vincent P. Mathews, M.D., professor of radiology at the Indiana University School of Medicine, and Howard A. Rowley, M.D., chief of radiology and Joseph Sackett Professor of Radiology at the University of Wisconsin at Madison, such imaging techniques can improve the selection process for thrombolysis and expand treatment beyond the current three-hour limit for tissue plasminogen activator (tPA), the clot buster that has been available for more than 10 years, but is used in less than 4% of the 750,000 new stroke patients each year.
Although the September issue highlights medical imaging, it also touches on other topics. We also have Simon Hayhurst’s second part of a two-part installment on scalable graphics (page 16), Dave Jackson and Bruce Tannenbaum’s collaboration on the benefits of Model-Based Design (page 26), my Product Feature on image analysis software (page 32) and Matt Szymanski’s article on CAVELib support for PC-based viz-clusters (page 39). This shows that meat and potatoes are not enough; sometimes, a little variety in the menu is in order.